Purchase Order 75F40121P00396
Award Date
8/10/21
Potential Completion Date
8/9/22
Potential Value
$23K
Federal Agency
Food and Drug Administration
Awardee
Genoway
Ultimate Awardee
Not listed
NAICS Category
621511 - Medical Laboratories
PSC Category
B537 - Special Studies/Analysis- Medical/Health
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Takoma Park, MD 20901, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Genoway has been awarded a firm fixed price purchase order valued at twenty-eight thousand nine hundred thirty-three dollars by the Department of Health and Human Services Food and Drug Administration to develop a RFWD2 conditional knock-out mouse line. The period of performance is scheduled to conclude on July 12, 2021. No set-aside designation was utilized for this procurement. Genoway is a for-profit biotechnology firm that specializes in developing genetically modified mouse, rat, and cell...
This is a Firm Fixed Price Delivery Order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services, to Ozgene PTY LTD, an Australian company that provides genetically modified mice and related services to support biomedical research. The contract, valued at $114,900.00, is for the provision of gene targeting vectors, mouse backcrossing, and the creation of gene...
The Department of Health and Human Services' National Institutes of Health's National Institute of Child Health and Human Development awarded an $8,161 purchase order to Genoway of France. The firm fixed price contract is for the development of an H3.3B conditional knockout ES cell mouse line, with performance taking place in France from September 23, 2014 through October 27, 2014. No additional context was provided regarding the agency's programs or any associated vehicles or set asides.
This is a firm-fixed price purchase order contract awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services, to Gempharmatech LLC, a foreign-owned for-profit biotechnology company. The contract is for the delivery of conditional knockout mouse lines to support NICHD's research programs. The total ceiling value of the contract is $11,930, and the period of performance is through January 15, 2023....
This is a firm fixed price purchase order contract awarded by the National Institute on Aging (NIA), a civilian agency within the National Institutes of Health (NIH), to Gempharmatech LLC, a foreign-owned for-profit biotechnology company. The contract is for the delivery of specialized Kremen1-flox mice, which are a type of knockout mouse model, to support preclinical drug discovery and development research. The contract has a ceiling value of $13,509.55 and a completion date of November 19,...
This federal contract award is for a delivery order issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The prime contractor is Ozgene PTY LTD, an Australian company that provides genetically modified mice and related services to support biomedical research. The award, valued at $7,286.00, is for additional breeding and other services to support gene targeting,...
The Department of Health and Human Services' National Institutes of Health's National Institute of Child Health and Human Development awarded a $17,000 firm fixed price purchase order to Genoway of France to provide "OTHER FUNCTIONS - LAB WORK/INJECTION OF ES CELLS" from May 6, 2016 through September 16, 2016. The contract supports the NIH NICHD's research efforts through laboratory work and injection of embryonic stem cells. Genoway will serve as the prime contractor on this...
The National Institutes of Health's National Institute of Child Health and Human Development awarded a $17,000 firm fixed price purchase order to Genoway of France to provide services related to the injection of targeted embryonic stem cell blastocyst clones and other functions. The contract has a period of performance from March 28, 2016 through June 17, 2016 and will be carried out in France. No additional context was provided regarding the agency's programs or use of contract deliverables....
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services' National Institutes of Health (NIH), to Ozgene PTY LTD, an Australian company that provides genetically modified mice and related services to support biomedical research. The contract, valued at $8,576.00, is for the breeding of ONO HCF-1 conditional knockout mice for removal of FLPAMBIS. No set-aside...
This firm-fixed-price purchase order contract, valued at $13,594.30, was awarded by the National Institute on Aging (NIA), a civilian agency within the U.S. Department of Health and Human Services, to Cyagen Biomodels LLC, a for-profit biotechnology company located in Santa Clara, California. The contract is for the generation of a TBX3 conditional knockout mouse strain to support biomedical research. No small business set-aside was used for this award. Cyagen Biomodels LLC specializes in...